Over the last two decades, haematopoietic stem cell transplantation (HSCT) has been
explored as a potential therapeutic strategy for autoimmune diseases refractory to …

Introduction Autologous hematopoietic stem-cell transplantation (AHSCT) has become
increasingly popular in recent years as an effective treatment of immune-mediated …

Abstract Purpose of Review Autologous haematopoietic stem cell transplantation (AHSCT)
is increasingly considered a treatment option for patients with multiple sclerosis (MS), an …

In carefully selected patients, autologous haematopoietic stem cell transplantation (HSCT) is
a safe, highly effective and cost-saving treatment modality for treatment-resistant, and …

Autologous haematopoietic stem cell transplantation (AHSCT) is a treatment option for
aggressive forms of multiple sclerosis (MS) that has been derived from haematological …

These updated EBMT guidelines review the clinical evidence, registry activity and
mechanisms of action of haematopoietic stem cell transplantation (HSCT) in multiple …

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system that leads to
an inflammatory process resulting in demyelination and axonal degeneration. The most …

Multiple Sclerosis (MS) is a frequent demyelinating immune-mediated disease of the central
nervous system (CNS) that affects principally young adults and leads to severe physical and …

Multiple sclerosis (MS) is an inflammatory, putatively autoimmune disease, estimated to
affect more than 2 million people worldwide. It affects young adults, especially women. For …

It is widely accepted that the main common pathogenetic pathway in multiple sclerosis (MS)
involves an immune-mediated cascade initiated in the peripheral immune system and …